Predicting 3-month risk for adolescent suicide attempts among pediatric emergency department patients.
Cheryl A King, Jacqueline Grupp-Phelan, David Brent...
https://pubmed.ncbi.nlm.nih.gov/31328282/Actively Recruiting
Led by University of Ljubljana, Faculty of Medicine · Updated on 2025-03-28
400
Participants Needed
2
Research Sites
N/A
Total Duration
This research investigates self-harm behavior among adolescents at high risk, particularly those hospitalized for suicide risk in Slovenia. The study aims to develop better methods to identify acute and long-term risks, understand factors influencing self-harm and treatment success, and create guidelines for more effective care. About 200 hospitalized adolescents and an equal number of healthy adolescents will participate to help compare risk and protective factors. Participants will undergo several assessments, including demographic reviews, clinical diagnoses, psychological questionnaires and tests such as CSSRS, B-NSSI-AT, and ASHRS, social evaluations, and genetic analyses from blood samples. Data on self-harming and aggressive behaviors will be collected during hospitalization, with follow-ups at 6 and 18 months. Healthy adolescents will be assessed only at enrollment. Throughout the study, researchers will collect and securely store data respecting privacy regulations. They will monitor self-harm incidents and evaluate risk factors using questionnaires and genetic testing. The main outcomes measured include incidents of self-harm over about one year and prevention of self-harm within 12 weeks. Participants will receive usual treatment during the study, and the overall participation may last up to 18 months after hospitalization.
CONDITIONS
Self-harm Behaviour Among the Most At-risk Adolescents
M
Maja Drobnič Radobuljac
M
Maja Drobnič Radobuljac
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Ljubljana, Faculty of Medicine
Lead Sponsor
University Medical Centre Ljubljana
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Enrollment and hospitalisation period
Participants complete questionnaires and psychodiagnostic tests to assess general health, mental health status, trauma exposure, personality, and self-harm risk. Blood samples are collected for genetic analyses.
1 enrollment visit and multiple assessments during hospitalisation
Duration - Hospitalisation period until discharge
During hospitalisation, participants are tracked for autoaggressive and heteroaggressive events using daily assessments and incident reports.
Daily assessments during hospital stay and 1 discharge visit
Duration - Up to 18 months post hospitalisation
Participants are followed up at 6 and 18 months after discharge to reassess risk factors and self-harm behaviour using questionnaires and blood sampling.
2 follow-up visits at 6 and 18 months post discharge
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Cheryl A King, Jacqueline Grupp-Phelan, David Brent...
https://pubmed.ncbi.nlm.nih.gov/31328282/Ana Martín-Blanco, Marc Ferrer, Joaquim Soler...
https://pubmed.ncbi.nlm.nih.gov/25048180/Yemiao Gao, Yuke Xiong, Xia Liu...
https://pubmed.ncbi.nlm.nih.gov/33807669/Anja Turin, Klemen Dovč, Simona Klemenčič...
https://pubmed.ncbi.nlm.nih.gov/34140900/Jeffrey A Bridge, Tina R Goldstein, David A Brent
https://pubmed.ncbi.nlm.nih.gov/16492264/Sarah V Swannell, Graham E Martin, Andrew Page...
https://pubmed.ncbi.nlm.nih.gov/24422986/K L Jang, W J Livesley, P A Vernon...
https://pubmed.ncbi.nlm.nih.gov/9020996/Catherine R Glenn, E David Klonsky
https://pubmed.ncbi.nlm.nih.gov/21665881/M S Gould, S Wallenstein, M Kleinman
https://pubmed.ncbi.nlm.nih.gov/2293755/M S Gould, K Petrie, M H Kleinman...
https://pubmed.ncbi.nlm.nih.gov/7721521/University of Ljubljana, Faculty of Medicine
Lead Sponsor
University Medical Centre Ljubljana
Collaborating Sponsor